Cormorant Asset Management, LP - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 110 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.7%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2021$4,356,000
-61.2%
300,000
-45.5%
0.15%
-40.8%
Q1 2021$11,226,000
+14.9%
550,0000.0%0.25%
+7.3%
Q4 2020$9,773,000
+1.7%
550,000
-15.4%
0.23%
-37.0%
Q3 2020$9,611,000
+357.9%
650,072
+550.1%
0.37%
+362.5%
Q2 2020$2,099,000
-9.2%
100,0000.0%0.08%
-25.2%
Q1 2020$2,311,000
+78.5%
100,000
+100.0%
0.11%
+105.8%
Q4 2019$1,295,000
-94.3%
50,000
-94.3%
0.05%
-97.2%
Q4 2018$22,645,000
-37.0%
884,916
-19.6%
1.84%
-21.3%
Q3 2018$35,937,000
+21.9%
1,100,000
-15.4%
2.34%
+7.1%
Q2 2018$29,484,000
-6.5%
1,300,0000.0%2.18%
-7.1%
Q1 2018$31,525,000
+25.6%
1,300,000
+44.4%
2.35%
-10.6%
Q4 2017$25,101,000
-22.8%
900,000
-5.3%
2.63%
-54.2%
Q3 2017$32,528,000
-14.1%
950,0000.0%5.74%
-8.5%
Q2 2017$37,848,000
-27.9%
950,000
-33.3%
6.27%
-17.7%
Q1 2017$52,469,000
+15.5%
1,425,0000.0%7.62%
+24.4%
Q4 2016$45,429,000
+12.1%
1,425,000
+27.4%
6.12%
+37.0%
Q3 2016$40,530,000
+59.7%
1,118,3720.0%4.47%
+24.2%
Q2 2016$25,376,0001,118,3723.60%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 10,898,879$264,297,00023.51%
Foundation Asset Management, LP 399,537$9,689,0003.59%
Cormorant Asset Management, LP 1,300,000$31,525,0002.35%
Baupost Group 9,309,168$225,747,0002.18%
Old West Investment Management, LLC 109,320$2,651,0001.53%
SENZAR ASSET MANAGEMENT, LLC 187,856$4,555,0001.44%
Chescapmanager LLC 350,631$8,503,0001.27%
Virtus ETF Advisers LLC 32,989$800,0000.69%
Rock Springs Capital Management LP 652,600$15,826,0000.68%
NJ State Employees Deferred Compensation Plan 34,142$828,0000.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders